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A “Proteomic Ruler” for Protein Copy Number
and Concentration Estimation without Spike-in
Standards*□S
Jacek R. Wis´niewski‡§¶, Marco Y. Hein‡§, Ju¨rgen Cox‡, and Matthias Mann‡¶
Absolute protein quantification using mass spectrometry
(MS)-based proteomics delivers protein concentrations or
copy numbers per cell. Existing methodologies typically
require a combination of isotope-labeled spike-in refer-
ences, cell counting, and protein concentration measure-
ments. Here we present a novel method that delivers
similar quantitative results directly from deep eukaryotic
proteome datasets without any additional experimental
steps. We show that the MS signal of histones can be
used as a “proteomic ruler” because it is proportional to
the amount of DNA in the sample, which in turn depends
on the number of cells. As a result, our proteomic ruler
approach adds an absolute scale to the MS readout and
allows estimation of the copy numbers of individual pro-
teins per cell. We compare our protein quantifications with
values derived via the use of stable isotope labeling by
amino acids in cell culture and protein epitope signature
tags in a method that combines spike-in protein fragment
standards with precise isotope label quantification. The
proteomic ruler approach yields quantitative readouts that
are in remarkably good agreement with results from the
precision method. We attribute this surprising result to the
fact that the proteomic ruler approach omits error-prone
steps such as cell counting or protein concentration mea-
surements. The proteomic ruler approach is readily appli-
cable to any deep eukaryotic proteome dataset—even in
retrospective analysis—and we demonstrate its usefulness
with a series of mouse organ proteomes. Molecular &
Cellular Proteomics 13: 10.1074/mcp.M113.037309, 3497–
3506, 2014.
Mass spectrometry (MS)1 is now capable of analyzing the
proteome to considerable depth, and more than 10,000 pro-
teins have been reported in single mammalian cell types (1). In
the past decade, MS-based proteomics has gone from sole
identification to the quantification of proteins, which has typ-
ically meant relative quantification between samples (2–4).
Apart from the presence of a protein and its relative fold
changes between different conditions (5), it is often desirable
to estimate absolute quantities such as molar concentrations
or copy numbers per cell, which can be compared for different
proteins (6). For instance, in systems biology, even a rough
estimate of the copy number can help to establish initial
parameters for simulation (7). Likewise, clinical protein mea-
surements are typically done in absolute terms of titers, such
as milligrams per deciliter. For this purpose various ap-
proaches have been utilized, including correlating total MS
signals to visualized structures in the cell (8) and extrapolating
from spiked-in reference protein mixtures (9) or from endog-
enous proteins quantified via accurately characterized, isoto-
pically labeled peptide (10) or protein fragment standards (11).
Absolute quantification is then achieved through quantifica-
tion relative to a known reference. In all cases, results scale
with the amount of input material or amount of spiked-in
standard. Accurate protein concentration measurements are
thus an essential and often limiting factor for overall accuracy.
Commonly used dye-based protein determination methods
rely on the reactivity of few amino acid residues—mainly
tryptophan and tyrosine (12) in the case of the Lowry and BCA
assays, or a hydrophilic/hydrophobic balance of the proteins
in the case of Bradford reagent (13). Systematic errors of up to
a factor of 2 may therefore arise from the selection of a
non-optimal protein standard (14). An additional, often ig-
nored source of errors is the cross-reactivity of the reagents
with non-proteinaceous cell components such as thiols, nu-
cleic acids, and phospholipids.
To convert protein quantities to copies per cell, all methods
require knowledge of the number of cells used for the analy-
sis. This can be obtained directly via cell counting or indirectly
through knowledge of the total protein amount per cell, which
in turn is a function of cell volume and total protein concen-
tration. However, cells are not necessarily uniform; therefore
scaling by cell numbers may be inaccurate, as a 25% variation
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of the diameter of a sphere-shaped cell corresponds to a
2-fold change in cell volume. In tissues, not only are cell sizes
variable, but visual counting of cells is also problematic. For
instance, up to 5-fold differences in calculated cell volumes
have been reported for enterocytes of the intestinal mucosa
(15).
Any deviations in protein determination or cell counts will
inevitably carry over to the final readout, even when very
precise MS methods are used. This limits the overall accu-
racy, without showing up as a decrease in the precision of the
quantification, as measured by standard deviations or coeffi-
cients of variation.
In the course of studying the colon cancer proteome, we
recently devised a method for estimating absolute amounts of
individual proteins or protein classes based on the proportion
of their MS signals to the total MS signal (16). We termed the
method the Total Protein Approach, because we relate this
proportion to a total protein mass. To obtain copy numbers,
we specifically used the total protein mass per cell, which
needs to be determined or estimated separately.
In this study, we expanded the method by a concept we call
the “proteomic ruler” to further allow correct absolute scaling
of the readout without additional steps. We made use of the
defined amount of genetic information in each cell, encoded in
a known amount of DNA. We show that an accurate determi-
nation of the DNA content in a proteomic sample helps to
directly determine the number of cells. We then demonstrate
that the MS signal derived from histones, around which DNA
is wrapped in a defined ratio, can be used as a natural
standard in a whole proteome dataset. It serves as a pro-
teomic ruler that allows the estimation of total protein
amounts per cell. Thereby the quantitative readout can be
absolutely scaled to copies per cell without the need for cell
counting or protein concentration determination.
EXPERIMENTAL PROCEDURES
Plasma Lysate—The author’s blood was capillary-collected via skin
puncture of the middle finger. It was immediately supplemented with
0.05 M EDTA and centrifuged at 5000  g for 1 min to separate blood
cells from plasma. Plasma was diluted 10-fold with lysis buffer con-
taining 0.1 M Tris-HCl, pH 8.0, 0.1 M DTT, and 2% SDS, and the
mixture was incubated at 70 °C for 5 min.
Whole Cell and Tissue Lysates—U87-MG, A549, PC-3, and
Hep-G2 cells were grown in DMEM supplemented with 10% FBS and
1% streptomycin. The cells were harvested at 70% confluence
and dissolved in lysis buffer at 100 °C for 5 min. After being chilled to
room temperature, the lysates were briefly sonicated to reduce the
viscosity of the sample. Frozen mouse tissues (Pel-Freez, Rogers, AR)
were homogenized with T10 basics Ultra-Turrax dispenser in the lysis
buffer at a tissue-to-buffer ratio of 1:10. The homogenates were
incubated at 100 °C for 5 min. Finally, the cell and tissue lysates were
clarified by centrifugation at 16,000  g for 10 min.
Protein Determination—Protein content was determined using a
Cary Eclipse Fluorescence Spectrometer (Varian, Palo Alto, CA) as
described previously (17). Briefly, aliquots of 1 to 3 l of whole cell
lysates were mixed with 2 ml of 8 M urea in 10 mM Tris-HCl, pH 8.5.
The fluorescence was measured at 295 nm for excitation and 350 nm
for emission. The slits were set to 5 nm and 20 nm for excitation and
emission, respectively. Tryptophan was used as a standard. The
protein content was calculated from the following relationship: the
fluorescence of 0.1 g of tryptophan equals 9 g of total protein,
which reflects an average 1.1% weight content of tryptophan in whole
lysates of human cells.
Cell Counting—Tissue cultures were trypsinized at 37 °C for 2 min,
and the released cells were washed with PBS and collected at 1000
g for 1 min. Then the pellets were suspended in PBS and the cells
were stained with 0.2% Trypan Blue (Invitrogen). Cell counting was
carried out on an automated cell counter (Countess, Invitrogen).
FASP-based Protein Processing—Aliquots of lysates containing
100 g of total protein were processed according to the multi-enzyme
digestion FASP protocol (18). Briefly, protein lysates were depleted
from the detergent using 8 M urea in 0.1 M Tris/HCl, pH 8.5, thiols were
alkylated with iodoacetamide, and proteins were consecutively di-
gested with endoproteinase LysC and trypsin. Digests of plasma
fractions were fractionated using a pipette tip strong anion exchange
method into four and two fractions as described previously (19).
FASP-based Cleavage and Determination of RNA and DNA—After
collection of the peptides released by trypsin, the material remaining
in the filter was washed once with TE buffer (10 mM Tris-HCl, pH 8.0)
and then was digested with 0.5 l (0.5 U) of RiboShredder (Epicenter,
Madison, WI) in 60 l of TE buffer at 37 °C for 1 h to digest RNA. The
released ribonucleotides were collected via centrifugation at
14,000  g. Next the material on filters was washed twice with 80 l
of TE buffer, and then it was cleaved with 6 g of DNAse (DN25,
Sigma, St. Louis, MO) in 60 l of 10 mM Tris-HCl, pH 7.8, containing
2.5 mM MgCl2 and 0.5 mM CaCl2 at 37 °C for 1 h. The obtained
deoxynucleotides were collected via centrifugation. The RNA and
DNA contents were determined by means of UV spectrometry using
extinction coefficients of 0.025 and 0.030 (g/ml)1cm1 at 260 nm,
respectively. The ratio of the spectral densities at 260 nm to 280 nm
was 2, indicating an absence of protein contamination that could
contribute to A260 measurement.
LC-MS/MS and Data Analysis—Peptides were quantified by tryp-
tophan fluorescence as described above, with the exception that the
measurements were performed directly in 0.2 ml of 0.05 M Tris/HCl,
pH 8.5, in 5 mm  5 mm quartz cells. 4-g aliquots of total peptide
were loaded onto C18 reverse phase columns (20 cm long, 75 m
inner diameter, in-house packed with ReproSil-Pur C18-AQ 1.8-m
resin (Dr. Maisch GmbH, Ammerbuch-Entringen, Germany)) with
buffer A (0.5% acetic acid). Peptides were eluted with a linear gradi-
ent of 5% to 30% buffer B (80% acetonitrile and 0.5% acetic acid) at
a flow rate of 250 nl/min over 195 min. This was followed by 10 min
from 30% to 60% buffer B, a washout of 95% buffer B, and re-
equilibration with buffer A. Peptides were electrosprayed and ana-
lyzed on Q Exactive mass spectrometers using a data-dependent
top-10 method with higher energy collisional dissociation fragmenta-
tion. Mouse organ samples were loaded onto a 15-cm reverse-phase
column packed with 3-m resin, separated over 320 min of gradient
time, and analyzed on an LTQ Orbitrap mass spectrometer using
collision-induced dissociation fragmentation. MS data were analyzed
using the MaxQuant software environment (20), version 1.3.10.18,
and its built-in Andromeda search engine (21). Proteins were identi-
fied by searching MS and MS/MS data against the human and mouse
complete proteome sequences from UniProtKB (May 2013 version
containing 88,820 and 50,807 sequences, respectively). Carbami-
domethylation of cysteines was set as a fixed modification. N-terminal
acetylation and oxidation of methionines were set as variable modi-
fications. Up to two missed cleavages were allowed. The initial al-
lowed mass deviation of the precursor ion was up to 6 ppm, and for
the fragment masses it was up to 20 ppm (higher energy collisional
dissociation, Orbitrap readout) and 0.5 Da (collision-induced dissoci-
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ation, ion trap readout). The mass accuracy of the precursor ions was
improved by time-dependent recalibration algorithms of MaxQuant.
The “match between runs” option was enabled to match identifica-
tions across samples within a time window of 30 s of the aligned
retention times. The maximum false peptide and protein discovery
rates were set to 0.01. Protein matching to the reverse database and
proteins identified only with modified peptides were filtered out. Pro-
tein abundances and copy numbers were calculated on the basis of
summed peptide intensities of unique and “razor” peptides as re-
ported by MaxQuant using the Perseus plugin described in this study.
Finally, we removed all protein groups with fewer than two unique
peptides (with the exception of two isoforms of creatine kinase in our
plasma analysis), as they were less likely to yield highly accurate copy
numbers.
Software Availability—The proteomic ruler Perseus plugin is avail-
able as a source code and as compiled binary from the Perseus
website.
RESULTS
The Total Protein Approach Gives Accurate Estimates of
Protein Concentrations—Using our Total Protein Approach,
we previously demonstrated that a protein’s abundance
within the cell as a fraction of the total protein is reflected by







This proportion can easily be extracted from any MS-based
proteomics measurement, and its accuracy will improve with
the depth of measurement. The value has to be scaled by a
total protein mass, which can conceptually be the entire pro-
tein amount of a cell, the protein amount in a given volume of
body fluid, or even a fixed unit such as 1 g. In that way we
obtain the absolute amount of the protein or protein class per
cell, per unit of volume, or per 1 g of total protein. To show
that this principle is universally applicable, beyond the cell line
and cancer tissue cases that we investigated before (16), we
used it to estimate the concentrations of different diagnosti-
cally relevant proteins or protein classes in blood plasma after
digesting plasma proteins using the FASP method (18). The
total protein concentration in plasma varies around a typical
value of 70 g/l within a narrow margin (22), so we scaled the
MS readout by a total amount of 70 g to obtain grams per liter.
We were able to quantify proteins within their expected phys-
iological ranges over at least 5 orders of magnitude (Fig. 1,
supplemental Table S1).
Nucleic Acid Quantification and Cell Counting via FASP-
based Sample Preparation—In the case of a body fluid such
as plasma, the total protein concentration is a readily acces-
sible scaling parameter, and protein concentrations are
meaningful and relevant. In the case of a cellular proteome,
however, many applications require quantities of copies per
cell, which necessitates cell counting. We wondered whether
cell counting could be replaced by accurate DNA quantifica-
tion when the genome size and ploidy were known. DNA
concentration was shown to be proportional to the cell count
and was successfully used to normalize enzyme activities,
transcript and protein amounts, and metabolome data (23–
25). We hypothesized that DNA quantities could be measured
directly from the proteomic sample, provided that the chro-
matin fraction was retained during sample preparation. In
contrast to in-solution or in-gel approaches, the FASPmethod
is reactor based (26) and allows sequential processing of the
sample and separation of reaction products. Detergents are
washed out at the beginning of the FASP procedure, and RNA
and DNA, the major components remaining after protease
digestion, can be cleanly released from the filter via RNase or
DNase digestion (Fig. 2A). To test the feasibility of nucleic acid
determination in the FASP format after digestion of proteins
and elution of peptides, we consecutively digested the mate-
rial retained on the filter with RNase and DNase. After each
cleavage we collected the digestion products and determined
their content based on UV absorbance at 260 nm. We ob-
served a linear correlation between the amount of the eluted
nucleotides and the amount of the sample. In parallel, we
processed samples supplemented with defined amounts of
purified calf thymus RNA and DNA. Yields were greater than
95% and were independent of the protein content (Fig. 2B),
indicating that post-FASP digestion of a sample with DNase
and RNase is a suitable method for determination of the RNA
and DNA content in a proteomic sample that does not require
additional preparative steps.
Next, we processed aliquots of total lysates prepared from
counted numbers of four different human cell lines using
two-step LysC/trypsin digestion of the proteins (multi-enzyme
digestion FASP) (27). Both the starting protein amounts and
the generated peptides were quantified. We then quantified
the ribonucleotides and deoxyribonucleotides eluted after
RNase and DNase treatment, respectively. The tryptic and
LysC peptides obtained in the multi-enzyme digestion FASP-
processed cell lysates (above) were analyzed in 4-h LC-











FIG. 1. Analysis of protein abundances in human plasma using
the Total Protein Approach.Whole plasma was processed using the
multi-enzyme digestion FASP approach with strong anion exchange
peptide fractionation before LC-MS/MS analysis as described in “Ex-
perimental Procedures.” Quantifications of selected target proteins
are indicated as black dots; the reference values (red bars) are from
Refs. 22 and 41. Two isoforms of creatine kinase were identified with
one peptide each, for which we provide annotated MS/MS spectra in
supplemental Fig. S1.
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MS/MS runs. In triplicate analyses, MaxQuant identified about
7000 proteins in each of the cell lines (supplemental Table S1).
The human genome contains around 3.2  109 base pairs
(28). Multiplying this number by the average mass of a base
pair (615.9 Da) and by the ploidy of the respective cell type
yields an expected amount of cellular DNA. We used a value
of 6.5 pg for a diploid human cell to calculate cell numbers.
Dividing the total amount of protein input by these cell num-
bers, we obtained a protein mass per cell that was very similar
to that obtained by dividing the total protein input amount by
the counted cell numbers (supplemental Table S2).
Histones Serve as a “Proteomic Ruler” for Absolute Scaling
of Proteomic Data—In eukaryotic cells, DNA is packaged in
chromatin by histones, and the mass of the DNA is about
equal to the combined mass of histones (29). We therefore
wondered whether the summed intensity of histones in a
deep, eukaryotic proteome could serve as a proxy for the
amount of DNA and therefore for the cell number. There are
five major histone types, which are expressed in many iso-
forms and variants that are relevant for many aspects of
chromatin biology. For our approach, however, we employed
the summed MS signal of all histone-derived peptides, irre-
spective of which histone they mapped to or how they were
assembled in protein groups. This value reflects the cumula-
tive histone mass. In this way, we used the MS signal of an
entire class of proteins as a proteomic ruler and related it to a
quantity that is not directly amenable to mass spectrometry.
Our hypothesis of the histone proteomic ruler predicts the










In our four-cell-line dataset, the histone MS signal
amounted to 2.07% to 4.03% of the total MS signal. Equating
this fraction with 6.5 pg as the DNA mass of diploid human
cells, we obtained cellular protein masses within a factor of
1.24  0.29 compared with the value obtained via cell count-
ing (Fig. 3B; supplemental Table S2). This is close to the
hypothesized value of 1 and implies that the ratio of histone
MS signal to total MS signal allows the estimation of the total
cellular protein mass without any additional measurements.
The error of the histone MS signal fraction depends on how
accurately the histone MS signal and the total MS signal can
be determined. For histones, a large number of various post-
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FIG. 2. A, the proteomic workflow. Cells were counted and lysed in a buffer containing SDS. Protein concentrations in the whole lysates were
determined, and 100-g aliquots of the whole lysates were successively processed in the proteomic reactor (FASP) format. After detergent
removal, proteins were consecutively cleaved with endoproteinase LysC and trypsin. The released LysC and tryptic peptides were subjected
to proteomic analysis. Next, RNA and DNA were digested, and the released ribo- and deoxyribonucleotides were spectrophotometrically
quantified at 260 nm. Protein contents per single cell were calculated from the cell numbers and the protein concentrations. Alternatively,
values of protein mass of single cells were obtained from DNA contents and the protein concentrations. B, determination of the efficiency and
yield of RNase and DNase cleavages. Aliquots of mouse liver lysates were processed with the FASP method, and the residual high-molecular-
weight material was sequentially cleaved with RNase and DNase (labeled “samples digested with DNase and RNase”). The released ribo- and
deoxyribonucleotides were quantified spectrophotometrically at 260 nm. To demonstrate the completeness of digestion over the analyzed
range, samples were supplemented with constant amounts of 2 g of purified DNA or RNA prior to sample processing (labeled “samples 
2 g RNA/DNA digested with DNase/RNase”). To demonstrate the specificity of the initial RNase digestion, samples were supplemented with
DNA and digested with RNase (labeled “samples  2 g DNA digested with RNase”).
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acetylation, serine and threonine phosphorylation, and lysine
methylation being the most frequent. In most standard pro-
teomics workflows, these modifications are not routinely in-
cluded in the database search, and we were wondering
whether this affects the ratio of histone MS signal to total MS
signal, which is critical for our scaling approach. To address
this question, we searched the data again with combinations
of acetylation, phosphorylation, and methylation set as vari-
able modifications. Although individual histones had changes
in their relative abundances, in particular histone H3 (Figs.
4A–4C), the fraction of the cumulative histone to total MS
signal changed only by 5% to 10% (Fig. 4D). This indicates
that, with the exception of histone H3, the fraction of the MS
signal derived from histone peptides that have PTMs is low
and can be neglected in the overall data scaling process.
The accuracy of the total MS signal depends on the depth
of the proteomic analysis. To estimate the required depth for
a robust readout, we ranked all peptides by intensity and
calculated the histone-MS fraction as a function of the num-
ber of identified peptides (Fig. 4E). Because peptide intensi-
ties span many orders of magnitude, the most intense pep-
tides contribute a large part of the total intensity. Within the
first few thousand peptides, the histone fraction is overesti-
mated because histones contribute some of the most intense
peptides. From a depth of around 12,000 or more peptides,
however, the histone fraction stabilizes within tight margins.
This depth of analysis is easily attainable with minimal sample
fractionation and also with single run analyses on latest-
generation machines (30).
For each protein in the measured proteome, we can now
estimate its mass per cell solely from its MS signal as the
product of its MS signal fraction and the cellular protein mass.
This value easily converts to copies per cell.







 cellular protein mass
(Eq. 3)






where NA is Avogadro’s constant and M is the molar mass of
the protein.
Ribosomal Proteins as a Proteomic Ruler for Cellular RNA—
Next, we investigated whether the proteomic ruler concept is
also applicable to cellular RNA. Ribosomal RNA typically rep-
resents about 80% of total RNA (31), and in eukaryotic ribo-
somes there is a ratio of about 1:1 between RNA and protein
(32). The summed MS signal for all ribosomal proteins
amounted to values between 3.61% and 5.27% of the total
MS signal across the cell lines. We compared this result by
the biochemical quantification of the total RNA content using
the FASP method in relation to the total protein input (sup-
plemental Table S2). Our results were within a factor of 1.01
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FIG. 3. Estimation of protein mass
per cell using two biochemical ap-
proaches and the proteomic ruler
method. A, the histone proteomic ruler
concept. The mass of cellular DNA is
approximately equal to the protein mass
of histones. Relating the histone MS sig-
nal to the total MS signal therefore al-
lows one to estimate the protein mass
per cells at a given cell ploidy and ge-
nome size. This method requires neither
cell counting nor the determination of
protein concentration. B, C, comparison
of the values of total protein per cell
obtained based on cell counting, DNA
determination, and the histone pro-
teomic ruler method. D, cell sizes ob-
tained from retrospective analysis of
published proteome datasets of CD4 or
CD8a positive or double negative (DN)
dendritic cell subtypes and plasmacy-
toid dendritic cells (pDCs) (36). All values
represent the mean of two (cell counting)
or three replicates (DNA and histone pro-
teomic ruler quantifications)  S.D.
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0.13 of the biochemical measurements, indicating that the MS
signal of ribosomal proteins can indeed be used as a pro-
teomic ruler to estimate cellular RNA amounts.
Histone Proteomic Ruler Provides Estimates of Cell Sizes in
Tissues—Counting cells in tissue samples is not trivial. How-
ever, determining the DNA and RNA content using our pro-
teomic reactor format is equally straightforward as for cell
lines. We prepared lysates from mouse brain, liver, and thy-
mus; measured protein, RNA, and DNA contents; and per-
formed proteomic analysis. There was excellent agreement
between the total cellular protein mass values derived from
the DNA-based method and our histone proteomic ruler ap-
proach (Fig. 3C; supplemental Table S3). This demonstrates
that the histone proteomic ruler serves as a good proxy for
estimating cellular protein masses in tissues.
The total cellular protein concentration typically lies within a
range of 20% to 30% (w/v) (i.e. 200 to 300 g/l) in many cell
types and organisms (33). This constraint can be used to
convert between cellular protein mass and cell volume. Hepa-
tocytes, the predominant cell type in liver, are roughly cubical
cells with a 15-m edge length (34). Assuming a total protein
concentration of 200 g/l, this translates to 675 pg of protein
per cell. This compares to our estimate of 464  35 pg total
protein per average liver cell, which is reasonable given that
non-hepatocytes contribute the same amount of DNA or his-
tones but less overall protein mass. Thymocytes are at the
other end of the size scale with an average volume of 250 m3
(35). This translates to 50 pg of protein, as compared with our
estimate of 59  31 pg.
To test the applicability of the histone proteomic ruler to the
retrospect analysis of existing datasets, we reevaluated whole-
proteome measurements of murine dendritic cell populations
published by our group in 2010 (36). Samples had been pre-
pared via one-dimensional SDS gel electrophoresis followed by
in-gel digestion, an approach distinct from our FASP-based
method and incompatible with direct DNA quantification from
the proteomic sample. Mature dendritic cells have diameters
between 10 and 15 m (37). We compared these cell sizes to
our proteomic ruler estimates that ranged between 64 14 and
95  25 pg total protein per cell for the different dendritic cell
subtypes (Fig. 3D). These values translated to diameters of 8.5
to 9.7 m for spherical cell shapes, which is expected to be
slightly smaller than observed cell sizes, given the numerous
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FIG. 4. The contribution of PTMs to the estimated total protein content of histones. Comparison of the fractions of the MS signals of
individual histones, accumulated by histone type, derived by including different combinations of variable modifications in the database search.
A, no variable PTMs (except for the default methionine oxidation and N-terminal acetylation). B, lysine acetylation and serine/threonine/tyrosine
phosphorylation. C, lysine mono-, di-, and trimethylation in addition to the modifications searched in B. Comparison of the sum of all histone
MS signals without PTMs (from A) and with all PTMs (from C). D, histone MS signal fraction as a function of the depth of analysis, simulated
by intensity-based ranking of peptides.
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observed similarities in cell sizes correlate with overall patterns
of proteomic similarity on the level of individual proteins that
were observed in the original study (36).
Label-free Copy Number Estimations Are Strikingly Close to
Precise Spike-in Quantifications—We previously employed
spiked-in protein epitope signature tags (PrESTs) of known
quantities in combination with isotopic labeling, cell counting,
and total protein concentration determination to obtain highly
reliable copy number values of selected proteins (11). To
assess the accuracy of our proteomic-ruler-derived protein
copy numbers, we reanalyzed the same dataset used in the
original PrEST-SILAC study and applied our calculations on
the “heavy” labeled proteome without considering the ratio
information from the “light” PrEST peptides. We recapitulated
not only the correct scaling of the total protein mass, but also
the copy numbers of the individual PrEST-quantified proteins
within an average deviation of 1.5-fold (Fig. 5A; supplemental
Table S4) and comparable precisions judged by the standard
deviations from three replicates. We attribute the surprisingly
good performance of the proteomic ruler quantifications to
the fact that our label-free quantification on average made use
of 19.4 peptides along the entire length of the proteins,
whereas the PrEST-SILAC quantification used 4.7 peptides
on average. This might compensate for some of the principal
limitations of the label-free approach. Looking at the devia-
tions of individual quantifications, we saw that the minority of
larger deviations occurred exclusively with PrEST-SILAC
quantifications based on two or fewer peptides or label-free
quantifications based on 11 or fewer peptides (Fig. 5B). This
observation underlines the benefits of approaches that rely on
multiple independent quantifications instead of single peptide
ratios, as commonly used, for example, with AQUA peptides.
We conclude that for those proteins quantified with more than
a few peptides, the proteomic ruler approach could offer a
surprisingly high level of accuracy, making it an attractive
alternative to label-based methods.
In addition to the comparison with spike-in quantification
data, macromolecular complexes offer another option for val-
idating protein copy numbers. Many obligate protein com-
plexes are well characterized in terms of their composition
and stoichiometry with subunits expressed at equimolar lev-
els. Fig. 5C shows that our histone proteomic-ruler-derived
copy numbers of members of the pyruvate dehydrogenase
complex and the TRiC chaperone closely match the expected
1:1 stoichiometry among subunits.
The Muscle Proteome Is Quantitatively Dominated by Large,
Abundant Proteins—As a practical example of the usefulness
of “easy” absolute protein quantification, we determined cell
sizes and cellular copy numbers of proteins in a panel of other
mouse organs (Fig. 6A). Ovaries consist predominantly of
small follicular cells and showed the least protein per cell (42
pg). Leg muscle cells, in contrast, had around 675 pg of
protein per nucleus. Considering that muscle fibers are syn-
cytial, multi-nucleated cells, the histone proteomic ruler de-
livered protein amounts per nucleus and not per cell in this
particular case. Despite the huge differences in cellular pro-
tein amounts, we observed much less variation in the depend-
ence of the abundance of a protein and its molecular mass,
irrespective of the tissue of origin. This is reflected in the
average molecular mass of a protein, which is calculated as
the ratio of the total protein mass per cell to the total number
of protein molecules (Fig. 6B). This number is rather similar
across tissues, with the notable exception of muscle tissues.
The reason for this becomes apparent when we look at the
distribution of protein sizes across the dynamic range of
the individual proteins (Figs. 6C and 6D). Independent of the
tissue of origin, low-abundant proteins had an average mo-
lecular mass of around 100 kDa, and this value decreased


























































































































FIG. 5. Comparison of absolute protein abundances calculated using the spike-in and proteomic ruler approaches. A, comparison of
protein copy numbers of selected proteins in HeLa cells obtained using spiked-in protein fragments (PrESTs) of known quantities and isotopic
label quantification (11) to those calculated using the label-free histone proteomic ruler method. Values represent the mean of three
replicates  S.D. B, comparison of the numbers of peptides overlapping with the PrEST standard used for the SILAC quantification and the
total number of peptides used for the proteomic ruler quantification. The deviations of the label-free values from the PrEST-SILAC values are
represented as the sizes of the points. C, D, label-free protein copy number estimates correlate with the composition of protein complexes.
C, pyruvate dehydrogenase complex. D, TRiC chaperonin.
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with increasing cellular abundance of the proteins to around
40 kDa for the most abundant proteins. This dependence was
observed in earlier studies and is thought to reflect the evo-
lutionary advantage of decreasing the size of abundant pro-
teins for reasons of biosynthetic cost (38). As a consequence
of this trend, the average molecular mass of a protein in a cell
is much smaller than the nominal average of the sizes of all
proteins when their abundances are not taken into account.
Notably, in skeletal muscle cells, filaments and motorproteins
such as titin and myosins are notable exceptions to the trend
of abundant proteins being smaller, as they are both large
(150 kDa) and very abundant (1 million copies per cell) in
this tissue, resulting in a profound increase in the average
molecular protein mass in a muscle cell (Fig. 6C, circles).
Plugin for the Perseus Data Analysis Software for Calcula-
tion of Absolute Protein Abundances—The calculation of the
protein abundances is a simple arithmetic task and can be
performed using commonly available table calculation tools.
To make the proteomic ruler approach easily usable for a wide
community, we have implemented it as a plugin for the Per-
seus data analysis software. Perseus is part of the freely
available MaxQuant suite (20). The proteomic ruler plugin
supports all modes of label-free absolute quantification de-
scribed in this study and takes user-configurable variables
such as the ploidy and the total protein concentration. Op-
tionally, it can incorporate an additional level of protein-spe-
cific correction: our copy number calculation assumes a direct
proportionality between a protein’s cumulative mass in the
proteomic sample and the MS signals summed over all pep-
tides derived from it (see Eq. 3). Hence the protein’s molar
mass serves as a protein-specific normalization factor for
copy number estimation. Because the combination of the
sequence of a protein, the specificity of the protease used for
digestion, and the characteristics of the mass spectrometric
analysis can introduce protein-specific biases (39), our plugin
allows the user to employ alternative normalization factors,
such as the number of theoretically expected peptides that is
used by some methods (9, 40).
In addition, we have implemented auxiliary functionalities.
For instance, molecular weights and numbers of theoretical
peptides can be calculated from protein I.D.s in combination
with the FASTA database. Moreover, the plugin allows the
categorization of proteins according to the expected accu-
racy of absolute quantification: proteins having a high fraction




































































































































FIG. 6. Application of the histone proteomic ruler to the global characterization of proteomes. A, average total protein mass per cell.
B, average molecular masses of proteins. Values represent the mean of three replicates  S.D. C, D, abundant proteins tended to be smaller
than low-abundance proteins. Motorproteins and filaments were notable exceptions in skeletal muscle.
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ber of actually identified peptides, most of which are group-
unique, are expected to yield better quantification.
DISCUSSION
In this paper, we propose that accurate absolute quantifi-
cation is possible without the use of spike-in standards
through the use of a concept we call the “proteomic ruler.”
Using the MS signal derived from histones and relating it to
a known amount of DNA per cell provides accurate esti-
mates of the total protein amount per cell that can be used
as scaling factors for calculating cellular copy numbers of
any protein of interest. We note that our approach makes a
number of assumptions that allow us to omit any spike-in
standards. At the same time, it eliminates several experi-
mental steps such as cell counting and absolute protein
concentration determination, which are themselves prone to
errors, in particular stemming from issues with protein de-
termination assays.
We found the quantitative results of our proteomic ruler
approach to be typically within a factor of 2 of precision
measurements or literature values. Importantly, this informa-
tion comes for free, in that it incorporates absolute quantifi-
cation into any kind of in-depth proteome dataset, even in
retrospective analysis. The only prerequisite is a eukaryotic,
whole-cell proteome dataset where the chromatin fraction is
not over- or underrepresented as a result of sample handling.
The latter is a specific requirement for an accurate estimation
of the total protein mass per cell, but all whole proteome
datasets should aim at an unbiased representation of all pro-
tein classes. A reasonable depth of proteomic analysis is
needed to ensure a robust contribution of the histone MS
signal, but the necessary depth should be readily attainable
with many experimental setups. We expect that in the future,
more and more proteomics projects will reach the required
depth of proteome coverage and will be able to incorporate
absolute quantification via the histone proteomic ruler. Addi-
tionally, individual protein copy numbers will become more
accurate with increased peptide coverage in deep datasets.
Furthermore, we envision a generalization of the proteomic
ruler concept beyond using the histone signal to estimate
cellular protein amounts. For instance, using characteristic
protein classes such as membrane or mitochondrial proteins,
it should be possible to infer insights into subcellular archi-
tecture solely from proteomics datasets.
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